top of page
Dr. Steve Roffler
National Biotechnology Research Park (BioTReC research group)
Cancer Treatment, Nanomedicines
The glycosidic switch liposome (GSL) platform increases the power of nanomedicines by facilitating active loading, stable retention and safe delivery of drugs in liposomes.
bottom of page